Polyrizon Ltd. Prices $5M Direct Offering at Premium
Ticker: PLRZ · Form: 6-K · Filed: Dec 5, 2025 · CIK: 1893645
| Field | Detail |
|---|---|
| Company | Polyrizon Ltd. (PLRZ) |
| Form Type | 6-K |
| Filed Date | Dec 5, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $9.00, $4.97 million, $250,000 |
| Sentiment | bullish |
Sentiment: bullish
Topics: offering, equity-raise, registered-direct
TL;DR
Polyrizon just sold shares at $9, a premium to Nasdaq minimums, raising capital.
AI Summary
On December 5, 2025, Polyrizon Ltd. entered into a securities purchase agreement to sell 552,269 ordinary shares at $9.00 per share in a registered direct offering. This offering was priced at a premium to the Nasdaq Minimum Price.
Why It Matters
This registered direct offering at a premium suggests investor confidence and provides the company with capital, potentially for growth or operational expansion.
Risk Assessment
Risk Level: medium — While the offering is at a premium, direct offerings can sometimes signal a need for capital or dilute existing shareholders.
Key Numbers
- $5.0M — Offering Proceeds (Calculated from 552,269 shares at $9.00 per share, representing capital raised.)
- $9.00 — Share Price (The price at which ordinary shares were sold in the registered direct offering.)
Key Players & Entities
- Polyrizon Ltd. (company) — Filing company
- December 5, 2025 (date) — Date of securities purchase agreement and offering
- 552,269 (number) — Number of ordinary shares sold
- $9.00 (dollar_amount) — Purchase price per ordinary share
FAQ
What is the total amount of capital Polyrizon Ltd. raised from this offering?
Polyrizon Ltd. raised approximately $5.0 million from the sale of 552,269 ordinary shares at $9.00 per share.
When did the securities purchase agreement for this offering take place?
The securities purchase agreement was entered into on December 5, 2025.
What type of securities were sold in the offering?
The company sold its ordinary shares, no par value per share.
Was the offering price at a discount or premium to the Nasdaq Minimum Price?
The offering price of $9.00 per Ordinary Share represented a premium to the Nasdaq Minimum Price.
What is the company's principal executive office address?
The company's principal executive offices are located at 5 Ha-Tidhar Street Raanana, 4366507, Israel.
Filing Stats: 800 words · 3 min read · ~3 pages · Grade level 13.7 · Accepted 2025-12-05 06:52:44
Key Financial Figures
- $9.00 — Offering”) at a purchase price of $9.00 per Ordinary Share. The offering price
- $4.97 million — ompany are expected to be approximately $4.97 million. The Company expects to use the net pro
- $250,000 — apital Corp a financial advisory fee of $250,000. The securities described above and to
Filing Documents
- ea0268528-6k_polyrizon.htm (6-K) — 17KB
- ea026852801ex5-1_polyrizon.htm (EX-5.1) — 10KB
- ea026852801ex10-1_polyrizon.htm (EX-10.1) — 194KB
- ex5-1_001.jpg (GRAPHIC) — 15KB
- 0001213900-25-118454.txt ( ) — 242KB
Forward Looking Statements
Forward Looking Statements This Report contains statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward looking statements are based upon the Company’s present intent, beliefs or expectations, but forward looking statements are not guaranteed to occur and may not occur for various reasons, including some reasons which are beyond the Company’s control. For example, this Report states that the Offering is expected to close on or about December 5, 2025. In fact, the closing of the Offering is subject to various conditions and contingencies as are customary in securities purchase agreements in the United States. If these conditions are not satisfied or the specified contingencies do not occur, this Offering may not close. For this reason, among others, you should not place undue reliance upon the Company’s forward looking statements. Except as required by law, the Company undertakes no obligation to revise or update any forward looking statements in order to reflect any event or circumstance that may arise after the date of this Report on Form 6-K. 1 EXHIBIT INDEX Exhibit No. 5.1 Opinion of Meitar | Law Offices, Israeli counsel to the Company 10.1 Form of Securities Purchase Agreement 23.1 Consent of Meitar | Law Offices (included in Exhibit 5.1) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Polyrizon Ltd. Date: December 5, 2025 By: /s/ Tomer Izraeli Name: Tomer Izraeli Title: Chief Executive Officer 3